Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
BeiGene
Tag: BeiGene
Analyst Activity – Morgan Stanley Reiterates Overweight on Beigene (NASDAQ:BGNE)
ME Staff
-
March 21, 2018
0
Analyst Activity – Ladenburg Thalmann Financial Services Reiterates Buy on Beigene...
ME Staff
-
March 1, 2018
0
Analyst Activity – Maxim Group Reiterates Buy on Beigene (NASDAQ:BGNE)
ME Staff
-
February 7, 2018
0
Analyst Activity – Maxim Group Reiterates Buy on Beigene (NASDAQ:BGNE)
ME Staff
-
January 22, 2018
0
Beigene Ltd (ADR) (NASDAQ:BGNE): Here’s Our Take
ME Contributor
-
January 26, 2017
0
Movers and Shakers: Beigene Ltd (ADR) (NASDAQ:BGNE) and Proteostasis Therapeutics Inc...
Jennifer Aldershot
-
March 8, 2016
0
Two IPOs to Kick off 2016 in Biotech
ME Contributor
-
February 10, 2016
0
/* */
// AST – IMS - [MarketExclusive_ROS]